Comments
Sun Pharmaceutical Industries’ shares may gain on unit Taro Pharmaceutical Industries’ earnings.
Taro’s margins increased by 70 bps to a record of 81.4 per cent, beating estimates, according to analysts.
Taro says Q3 sales rose 11.3 per cent to $237.7 million.
Sun Pharma’s October-December earnings will beat estimates on account of Taro’s performance, according to traders.
The company will announce quarterly earnings on Saturday, says BSE data.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.